PRNewswire

– Encouraging preliminary anti-tumor activity observed in heavily pre-treated population – – At ≥ 90 mg QD, 6 out of 11 (54.5%) patients with FGFR3+ mUC achieved a confirmed partial response (PR), with 100% disease control rate and sustained duration of activity – – P

AKY-1189 is a novel Nectin-4 targeted radiopharmaceutical product candidate demonstrating substantial tumor uptake across several solid tumor types and is progressing in human development as a therapeutic agent AKY-1189 was engineered to deliver actinium-225 directly to tumors while minimizing expos

NEW YORK, Oct. 24, 2024 /PRNewswire/ — Report with market evolution powered by AI – The global meltblown nonwoven fabric market  size is estimated to grow by USD 2.8 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  7.75%  during the forec

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: